25 XP   0   0   10

Instituto Rosenbusch S.A.
Buy, Hold or Sell?

Let's analyse Rosenbusch together

PenkeI guess you are interested in Instituto Rosenbusch S.A.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Instituto Rosenbusch S.A.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Instituto Rosenbusch S.A.

I send you an email if I find something interesting about Instituto Rosenbusch S.A..

Quick analysis of Rosenbusch (30 sec.)










What can you expect buying and holding a share of Rosenbusch? (30 sec.)

How much money do you get?

How much money do you get?
ARS0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
ARS22.64
Expected worth in 1 year
ARS36.68
How sure are you?
67.5%

+ What do you gain per year?

Total Gains per Share
ARS14.03
Return On Investment
12.8%

For what price can you sell your share?

Current Price per Share
ARS109.50
Expected price per share
ARS60.00 - ARS135.00
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Rosenbusch (5 min.)




Live pricePrice per Share (EOD)

ARS109.50

Intrinsic Value Per Share

ARS62.37 - ARS74.65

Total Value Per Share

ARS85.01 - ARS97.29

2. Growth of Rosenbusch (5 min.)




Is Rosenbusch growing?

Current yearPrevious yearGrowGrow %
How rich?$1.1m$341.7k$352.7k50.8%

How much money is Rosenbusch making?

Current yearPrevious yearGrowGrow %
Making money$34.3k$4.1k$30.1k87.9%
Net Profit Margin0.4%1.6%--

How much money comes from the company's main activities?

3. Financial Health of Rosenbusch (5 min.)




3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Rosenbusch? (5 min.)

Welcome investor! Rosenbusch's management wants to use your money to grow the business. In return you get a share of Rosenbusch.

What can you expect buying and holding a share of Rosenbusch?

First you should know what it really means to hold a share of Rosenbusch. And how you can make/lose money.

Speculation

The Price per Share of Rosenbusch is ARS109.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Rosenbusch.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Rosenbusch, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ARS22.64. Based on the TTM, the Book Value Change Per Share is ARS3.51 per quarter. Based on the YOY, the Book Value Change Per Share is ARS1.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ARS0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Rosenbusch.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ARS% of Price per ShareARS% of Price per ShareARS% of Price per ShareARS% of Price per ShareARS% of Price per Share
Usd Eps0.010.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Book Value Change Per Share0.010.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.010.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Price Per Share0.04-0.03-0.01-0.01-0.01-
Price to Earnings Ratio1.48--2.68-13.84--46.46--18.65-
Price-to-Total Gains Ratio3.27-13.51-12.21-11.99--31.29-
Price to Book Ratio1.59-1.55-1.72-1.97-2.38-
Price-to-Total Gains Ratio3.27-13.51-12.21-11.99--31.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.1314
Number of shares7610
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (7610 shares)32.049.34
Gains per Year (7610 shares)128.1737.36
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1012811813627
2025624627364
303853743109101
405135024145138
506416305182175
607697586218212
708978867254249
80102510148291286
90115411429327323
1001282127010363360

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%5.07.00.041.7%6.014.00.030.0%16.014.010.040.0%55.014.026.057.9%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%15.05.00.075.0%26.014.00.065.0%67.028.00.070.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%1.00.019.05.0%1.00.039.02.5%13.00.082.013.7%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%16.04.00.080.0%27.013.00.067.5%71.024.00.074.7%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Rosenbusch

About Instituto Rosenbusch S.A.

Instituto Rosenbusch S.A. markets and manufactures veterinary products in Argentina. The company offers biological products, including products for reproductive-respiratory complex, IBR, BVD, brucelosis, carbuncle, and other diseases; clostridial vaccines; vaccines for cattle, sheep, goats, horses, and dogs; and products for the prevention of pneumonia and calve diarrhea, and cattle infectious keratoconjunctivitis. It also provides pharmaceutical products, such as external and internal antiparasitics, endectocides, antimicotics-bacteriostatics, injectable antibiotics, antimastitics, and other chemotherapics, as well as vitamins and minerals. The company was founded in 1917 and is based in Buenos Aires, Argentina.

Fundamental data was last updated by Penke on 2024-02-19 23:31:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Instituto Rosenbusch S.A..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Rosenbusch earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Rosenbusch to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 29.8% means that $0.30 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Instituto Rosenbusch S.A.:

  • The MRQ is 29.8%. The company is making a huge profit. +2
  • The TTM is 0.4%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ29.8%TTM0.4%+29.4%
TTM0.4%YOY1.6%-1.2%
TTM0.4%5Y-5.6%+6.0%
5Y-5.6%10Y0.4%-6.0%
1.1.2. Return on Assets

Shows how efficient Rosenbusch is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Rosenbusch to the Drug Manufacturers - Specialty & Generic industry mean.
  • 9.6% Return on Assets means that Rosenbusch generated $0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Instituto Rosenbusch S.A.:

  • The MRQ is 9.6%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 0.3%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ9.6%TTM0.3%+9.3%
TTM0.3%YOY0.6%-0.3%
TTM0.3%5Y-1.5%+1.7%
5Y-1.5%10Y0.0%-1.5%
1.1.3. Return on Equity

Shows how efficient Rosenbusch is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Rosenbusch to the Drug Manufacturers - Specialty & Generic industry mean.
  • 29.3% Return on Equity means Rosenbusch generated $0.29 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Instituto Rosenbusch S.A.:

  • The MRQ is 29.3%. Using its investors money, the company is very efficient in making profit. +2
  • The TTM is -1.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ29.3%TTM-1.4%+30.7%
TTM-1.4%YOY2.2%-3.7%
TTM-1.4%5Y-6.1%+4.6%
5Y-6.1%10Y-1.0%-5.1%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Instituto Rosenbusch S.A..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Rosenbusch is operating .

  • Measures how much profit Rosenbusch makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Rosenbusch to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Instituto Rosenbusch S.A.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM6.5%-6.5%
TTM6.5%YOY10.2%-3.7%
TTM6.5%5Y4.0%+2.5%
5Y4.0%10Y2.0%+2.0%
1.2.2. Operating Ratio

Measures how efficient Rosenbusch is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 2.19 means that the operating costs are $2.19 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Instituto Rosenbusch S.A.:

  • The MRQ is 2.193. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.298. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.193TTM3.298-1.105
TTM3.298YOY1.565+1.733
TTM3.2985Y1.947+1.351
5Y1.94710Y1.282+0.664
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Instituto Rosenbusch S.A..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Rosenbusch is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.61 means the company has $1.61 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Instituto Rosenbusch S.A.:

  • The MRQ is 1.608. The company is able to pay all its short-term debts. +1
  • The TTM is 1.576. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.608TTM1.576+0.032
TTM1.576YOY1.977-0.401
TTM1.5765Y1.422+0.154
5Y1.42210Y0.711+0.711
1.3.2. Quick Ratio

Measures if Rosenbusch is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Rosenbusch to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.48 means the company can pay off $0.48 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Instituto Rosenbusch S.A.:

  • The MRQ is 0.481. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.564. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.481TTM0.564-0.083
TTM0.564YOY0.735-0.171
TTM0.5645Y0.529+0.035
5Y0.52910Y0.713-0.185
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Instituto Rosenbusch S.A..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Rosenbusch assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Rosenbusch to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.64 means that Rosenbusch assets are financed with 64.4% credit (debt) and the remaining percentage (100% - 64.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Instituto Rosenbusch S.A.:

  • The MRQ is 0.644. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.703. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.644TTM0.703-0.059
TTM0.703YOY0.700+0.003
TTM0.7035Y0.712-0.009
5Y0.71210Y0.640+0.072
1.4.2. Debt to Equity Ratio

Measures if Rosenbusch is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Rosenbusch to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 197.2% means that company has $1.97 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Instituto Rosenbusch S.A.:

  • The MRQ is 1.972. The company is just able to pay all its debts with equity.
  • The TTM is 2.681. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ1.972TTM2.681-0.709
TTM2.681YOY2.612+0.069
TTM2.6815Y2.895-0.214
5Y2.89510Y2.193+0.702
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Instituto Rosenbusch S.A.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Rosenbusch generates.

  • Above 15 is considered overpriced but always compare Rosenbusch to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 1.48 means the investor is paying $1.48 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Instituto Rosenbusch S.A.:

  • The EOD is 4.496. Based on the earnings, the company is cheap. +2
  • The MRQ is 1.480. Based on the earnings, the company is cheap. +2
  • The TTM is -2.679. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD4.496MRQ1.480+3.016
MRQ1.480TTM-2.679+4.159
TTM-2.679YOY13.841-16.520
TTM-2.6795Y-46.457+43.778
5Y-46.45710Y-18.646-27.811
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Instituto Rosenbusch S.A.:

  • The EOD is 24.522. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 8.073. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 14.423. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD24.522MRQ8.073+16.449
MRQ8.073TTM14.423-6.350
TTM14.423YOY7.074+7.350
TTM14.4235Y4.257+10.166
5Y4.25710Y0.912+3.345
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Rosenbusch is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Instituto Rosenbusch S.A.:

  • The EOD is 4.836. Based on the equity, the company is fair priced.
  • The MRQ is 1.592. Based on the equity, the company is underpriced. +1
  • The TTM is 1.551. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD4.836MRQ1.592+3.244
MRQ1.592TTM1.551+0.041
TTM1.551YOY1.722-0.171
TTM1.5515Y1.967-0.416
5Y1.96710Y2.382-0.415
2. Total Gains per Share
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Instituto Rosenbusch S.A. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--11.0153.509+214%1.101+900%0.994+1008%0.531+1976%
Book Value Per Share--22.64513.588+67%6.686+239%6.166+267%3.997+467%
Current Ratio--1.6081.576+2%1.977-19%1.422+13%0.711+126%
Debt To Asset Ratio--0.6440.703-8%0.700-8%0.712-10%0.640+1%
Debt To Equity Ratio--1.9722.681-26%2.612-25%2.895-32%2.193-10%
Dividend Per Share----0%-0%0.028-100%0.014-100%
Eps--6.0890.672+806%0.109+5495%-0.040+101%0.016+37307%
Free Cash Flow Per Share--1.1160.368+203%0.222+404%0.261+327%0.188+495%
Free Cash Flow To Equity Per Share--1.1160.056+1905%-0.050+104%0.016+6944%0.024+4518%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.750+33%
Intrinsic Value_10Y_max--74.648--------
Intrinsic Value_10Y_min--62.368--------
Intrinsic Value_1Y_max--2.058--------
Intrinsic Value_1Y_min--2.018--------
Intrinsic Value_3Y_max--10.315--------
Intrinsic Value_3Y_min--9.764--------
Intrinsic Value_5Y_max--23.555--------
Intrinsic Value_5Y_min--21.508--------
Market Cap4662882300.000+67%1535350213.250909285077.750+69%466354641.750+229%474503616.263+224%348703211.781+340%
Net Profit Margin--0.2980.004+7062%0.016+1738%-0.056+119%0.004+8219%
Operating Margin---0.065-100%0.102-100%0.040-100%0.020-100%
Operating Ratio--2.1933.298-34%1.565+40%1.947+13%1.282+71%
Pb Ratio4.836+67%1.5921.551+3%1.722-8%1.967-19%2.382-33%
Pe Ratio4.496+67%1.480-2.679+281%13.841-89%-46.457+3238%-18.646+1360%
Price Per Share109.500+67%36.05021.350+69%10.950+229%11.142+224%8.188+340%
Price To Free Cash Flow Ratio24.522+67%8.07314.423-44%7.074+14%4.257+90%0.912+785%
Price To Total Gains Ratio9.941+67%3.27313.510-76%12.214-73%11.989-73%-31.293+1056%
Quick Ratio--0.4810.564-15%0.735-35%0.529-9%0.713-33%
Return On Assets--0.0960.003+3530%0.006+1520%-0.015+115%0.000+19631%
Return On Equity--0.293-0.014+105%0.022+1226%-0.061+121%-0.010+104%
Total Gains Per Share--11.0153.509+214%1.101+900%1.023+977%0.545+1922%
Usd Book Value--1157312.826694464.056+67%341699.942+239%315110.048+267%204245.602+467%
Usd Book Value Change Per Share--0.0130.004+214%0.001+900%0.001+1008%0.001+1976%
Usd Book Value Per Share--0.0270.016+67%0.008+239%0.007+267%0.005+467%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%
Usd Eps--0.0070.001+806%0.000+5495%0.000+101%0.000+37307%
Usd Free Cash Flow--57054.14018821.614+203%11320.996+404%13362.638+327%6950.068+721%
Usd Free Cash Flow Per Share--0.0010.000+203%0.000+404%0.000+327%0.000+495%
Usd Free Cash Flow To Equity Per Share--0.0010.000+1905%0.000+104%0.000+6944%0.000+4518%
Usd Market Cap5595458.760+67%1842420.2561091142.093+69%559625.570+229%569404.340+224%418443.854+340%
Usd Price Per Share0.131+67%0.0430.026+69%0.013+229%0.013+224%0.010+340%
Usd Profit--311171.18834334.130+806%4156.145+7387%-1333.899+100%1195.556+25927%
Usd Revenue--1043942.165708522.406+47%280884.136+272%293906.116+255%173407.403+502%
Usd Total Gains Per Share--0.0130.004+214%0.001+900%0.001+977%0.001+1922%
 EOD+4 -4MRQTTM+27 -6YOY+26 -75Y+26 -910Y+27 -9

3.2. Fundamental Score

Let's check the fundamental score of Instituto Rosenbusch S.A. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-154.496
Price to Book Ratio (EOD)Between0-14.836
Net Profit Margin (MRQ)Greater than00.298
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.481
Current Ratio (MRQ)Greater than11.608
Debt to Asset Ratio (MRQ)Less than10.644
Debt to Equity Ratio (MRQ)Less than11.972
Return on Equity (MRQ)Greater than0.150.293
Return on Assets (MRQ)Greater than0.050.096
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Instituto Rosenbusch S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.022
Ma 20Greater thanMa 50113.125
Ma 50Greater thanMa 10087.183
Ma 100Greater thanMa 20068.549
OpenGreater thanClose108.250
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Income before Tax  -15,299-12,842-28,141-1,481-29,622-20,779-50,400303,937253,537
Net Income  -20,794-10,060-30,854390-30,464-53,082-83,545342,854259,309
Net Income from Continuing Operations  -25,497-7,121-32,619-1,856-34,475-23,293-57,768298,342240,575



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in ARS. All numbers in thousands.

Summary
Total Assets2,709,267
Total Liabilities1,744,839
Total Stockholder Equity884,785
 As reported
Total Liabilities 1,744,839
Total Stockholder Equity+ 884,785
Total Assets = 2,709,267

Assets

Total Assets2,709,267
Total Current Assets2,072,956
Long-term Assets636,311
Total Current Assets
Cash And Cash Equivalents 162,571
Net Receivables 619,687
Inventory 961,683
Other Current Assets 363
Total Current Assets  (as reported)2,072,956
Total Current Assets  (calculated)1,744,303
+/- 328,653
Long-term Assets
Property Plant Equipment 629,355
Intangible Assets 3,113
Long-term Assets  (as reported)636,311
Long-term Assets  (calculated)632,468
+/- 3,843

Liabilities & Shareholders' Equity

Total Current Liabilities1,289,188
Long-term Liabilities455,651
Total Stockholder Equity884,785
Total Current Liabilities
Short Long Term Debt 277,744
Accounts payable 416,070
Other Current Liabilities 47,547
Total Current Liabilities  (as reported)1,289,188
Total Current Liabilities  (calculated)741,361
+/- 547,827
Long-term Liabilities
Long term Debt 295,997
Long-term Liabilities Other 12,989
Long-term Liabilities  (as reported)455,651
Long-term Liabilities  (calculated)308,986
+/- 146,665
Total Stockholder Equity
Total Stockholder Equity (as reported)884,785
Total Stockholder Equity (calculated)0
+/- 884,785
Other
Capital Stock42,589
Common Stock Shares Outstanding 42,589
Net Debt 411,170
Net Invested Capital 1,458,526
Net Working Capital 783,768
Property Plant and Equipment Gross 5,754,744



Balance Sheet

Currency in ARS. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-31
> Total Assets 
14,084
13,936
14,160
14,711
14,538
14,746
15,048
15,336
22,345
27,980
29,102
29,553
30,122
32,247
33,812
35,596
36,487
37,596
37,852
39,115
41,607
40,339
42,877
45,569
48,025
47,119
47,851
48,520
50,702
50,544
55,189
53,830
62,305
62,712
59,760
57,441
57,927
62,246
63,600
64,482
66,733
71,381
69,521
73,425
77,843
78,642
81,174
86,925
87,016
88,880
96,301
114,898
110,318
112,658
117,546
125,889
139,252
135,805
138,821
140,755
138,271
136,601
139,014
166,170
176,837
192,505
188,618
197,857
195,284
205,529
214,343
213,525
240,033
289,205
334,859
366,756
405,370
396,349
433,512
496,939
524,506
579,053
603,455
675,640
705,443
730,189
760,547
747,292
848,619
970,219
1,209,150
1,347,992
1,652,525
1,905,597
2,709,267
2,709,2671,905,5971,652,5251,347,9921,209,150970,219848,619747,292760,547730,189705,443675,640603,455579,053524,506496,939433,512396,349405,370366,756334,859289,205240,033213,525214,343205,529195,284197,857188,618192,505176,837166,170139,014136,601138,271140,755138,821135,805139,252125,889117,546112,658110,318114,89896,30188,88087,01686,92581,17478,64277,84373,42569,52171,38166,73364,48263,60062,24657,92757,44159,76062,71262,30553,83055,18950,54450,70248,52047,85147,11948,02545,56942,87740,33941,60739,11537,85237,59636,48735,59633,81232,24730,12229,55329,10227,98022,34515,33615,04814,74614,53814,71114,16013,93614,084
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
285,602
311,871
297,336
322,912
378,710
400,463
449,756
470,895
528,927
542,355
556,957
578,502
556,112
634,269
726,616
923,064
1,001,264
1,260,588
1,423,713
2,072,956
2,072,9561,423,7131,260,5881,001,264923,064726,616634,269556,112578,502556,957542,355528,927470,895449,756400,463378,710322,912297,336311,871285,602000000000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,932
12,993
12,567
21,970
15,755
11,577
22,435
35,869
47,903
41,172
46,329
51,992
56,956
71,094
78,493
87,802
106,595
88,463
120,124
162,571
162,571120,12488,463106,59587,80278,49371,09456,95651,99246,32941,17247,90335,86922,43511,57715,75521,97012,56712,99314,932000000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
5,702
5,576
5,399
6,019
5,986
6,405
6,384
6,532
10,892
9,413
9,750
10,045
11,614
11,971
12,887
11,044
13,598
12,866
13,323
15,916
18,361
16,141
16,745
18,235
23,126
19,850
19,396
22,248
22,129
22,038
25,648
24,201
25,940
24,110
25,257
23,966
28,983
31,170
31,308
32,315
35,168
34,775
29,783
34,330
36,944
39,398
40,328
35,975
34,901
33,868
32,522
38,156
40,528
38,935
36,957
43,539
52,537
51,094
50,805
47,948
51,935
49,695
52,911
69,405
73,599
89,917
86,193
82,777
86,384
96,260
98,169
98,662
114,012
140,937
159,174
135,382
128,197
105,851
130,617
135,643
143,039
163,084
163,135
171,413
199,314
200,787
210,396
198,194
223,212
257,217
393,169
332,305
487,039
611,990
619,687
619,687611,990487,039332,305393,169257,217223,212198,194210,396200,787199,314171,413163,135163,084143,039135,643130,617105,851128,197135,382159,174140,937114,01298,66298,16996,26086,38482,77786,19389,91773,59969,40552,91149,69551,93547,94850,80551,09452,53743,53936,95738,93540,52838,15632,52233,86834,90135,97540,32839,39836,94434,33029,78334,77535,16832,31531,30831,17028,98323,96625,25724,11025,94024,20125,64822,03822,12922,24819,39619,85023,12618,23516,74516,14118,36115,91613,32312,86613,59811,04412,88711,97111,61410,0459,7509,41310,8926,5326,3846,4055,9866,0195,3995,5765,702
       Other Current Assets 
459
458
515
463
459
407
409
578
525
722
670
796
751
801
738
792
918
1,333
2,878
1,133
1,037
1,041
1,106
1,045
770
652
474
532
461
474
475
523
2,436
2,352
2,671
1,138
649
678
841
904
1,201
1,446
673
892
835
901
813
872
1,858
189
1,313
20
131
1,626
1,877
2,598
2,274
2,247
1,831
4,137
3,440
3,535
1,671
4,137
4,036
4,145
3,783
6,264
6,789
4,028
4,830
4,468
3,836
4,367
7,030
2,323
405
363
3,489
363
1,610
6,051
3,265
9,283
4,598
9,573
3,165
3,159
6,801
11,456
3,456
36,055
23,324
27,105
363
36327,10523,32436,0553,45611,4566,8013,1593,1659,5734,5989,2833,2656,0511,6103633,4893634052,3237,0304,3673,8364,4684,8304,0286,7896,2643,7834,1454,0364,1371,6713,5353,4404,1371,8312,2472,2742,5981,8771,626131201,3131891,8588728139018358926731,4461,2019048416786491,1382,6712,3522,4365234754744615324746527701,0451,1061,0411,0371,1332,8781,333918792738801751796670722525578409407459463515458459
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
93,498
99,013
0
118,229
124,043
129,296
132,560
146,713
163,087
173,231
182,044
191,179
214,351
243,604
286,085
346,729
391,936
481,884
636,311
636,311481,884391,936346,729286,085243,604214,351191,179182,044173,231163,087146,713132,560129,296124,043118,229099,01393,4980000000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
3,286
3,255
3,181
3,147
3,164
3,190
3,192
3,047
3,739
5,627
5,892
5,762
5,355
5,630
5,710
5,753
6,430
6,661
3,893
5,690
5,677
5,720
5,924
6,594
7,419
7,450
7,886
8,240
8,298
8,766
8,942
8,973
7,182
8,014
7,977
8,212
7,538
7,848
8,908
11,851
8,637
8,785
9,841
9,819
11,195
11,397
15,271
16,947
17,542
18,027
17,351
21,481
22,762
24,546
24,572
25,123
25,098
24,782
24,351
24,411
24,130
24,303
23,597
25,844
26,875
29,885
29,349
32,029
30,771
30,767
31,224
31,029
31,297
34,813
39,853
79,173
91,306
96,837
108,104
115,470
121,061
126,028
129,031
142,849
158,773
168,486
176,875
185,532
208,655
232,694
275,503
334,345
384,801
475,359
629,355
629,355475,359384,801334,345275,503232,694208,655185,532176,875168,486158,773142,849129,031126,028121,061115,470108,10496,83791,30679,17339,85334,81331,29731,02931,22430,76730,77132,02929,34929,88526,87525,84423,59724,30324,13024,41124,35124,78225,09825,12324,57224,54622,76221,48117,35118,02717,54216,94715,27111,39711,1959,8199,8418,7858,63711,8518,9087,8487,5388,2127,9778,0147,1828,9738,9428,7668,2988,2407,8867,4507,4196,5945,9245,7205,6775,6903,8936,6616,4305,7535,7105,6305,3555,7625,8925,6273,7393,0473,1923,1903,1643,1473,1813,2553,286
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11
14
13
18
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000018131411000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
271
267
283
376
373
377
380
372
529
811
808
807
770
775
771
720
600
579
579
420
407
374
389
434
462
474
467
452
347
244
138
75
49
36
24
15
12
9
6
4
3
31
31
31
36
94
85
83
72
46
109
102
95
118
135
131
128
125
109
93
105
81
57
34
28
23
18
1
1
1
1
1
1
1
0
1
1
1
0
0
0
0
65
0
63
60
50
48
42
2,479
2,714
3,250
4,185
2,892
3,113
3,1132,8924,1853,2502,7142,479424850606306500001110111111118232834578110593109125128131135118951021094672838594363131313469121524364975138244347452467474462434389374407420579579600720771775770807808811529372380377373376283267271
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
93,498
99,013
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000099,01393,4980000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
2,701
2,529
2,569
2,812
2,209
2,149
2,271
2,747
5,223
5,272
5,478
5,387
5,243
5,371
5,663
7,331
7,059
8,059
7,786
8,707
8,791
7,781
9,451
11,434
11,469
11,392
12,381
12,551
13,189
13,945
18,576
16,335
15,161
15,321
13,802
11,796
13,101
15,756
16,112
17,537
18,457
20,646
19,701
23,227
25,241
24,171
24,574
30,678
30,254
27,338
33,552
49,018
45,599
49,836
57,062
68,238
68,833
70,963
67,142
72,511
70,140
71,547
77,117
95,550
104,128
116,461
113,587
114,621
108,894
116,070
125,516
126,947
152,859
194,221
217,474
220,806
243,841
257,198
314,837
381,422
392,962
424,705
459,945
527,946
541,493
533,167
581,478
548,103
593,508
652,204
842,465
947,478
1,197,906
1,410,277
1,744,839
1,744,8391,410,2771,197,906947,478842,465652,204593,508548,103581,478533,167541,493527,946459,945424,705392,962381,422314,837257,198243,841220,806217,474194,221152,859126,947125,516116,070108,894114,621113,587116,461104,12895,55077,11771,54770,14072,51167,14270,96368,83368,23857,06249,83645,59949,01833,55227,33830,25430,67824,57424,17125,24123,22719,70120,64618,45717,53716,11215,75613,10111,79613,80215,32115,16116,33518,57613,94513,18912,55112,38111,39211,46911,4349,4517,7818,7918,7077,7868,0597,0597,3315,6635,3715,2435,3875,4785,2725,2232,7472,2712,1492,2092,8122,5692,5292,701
   > Total Current Liabilities 
2,454
2,340
2,381
2,656
1,841
1,999
2,123
2,601
4,916
5,008
5,221
5,143
5,034
5,040
4,925
6,590
6,141
7,137
6,774
7,709
7,792
6,785
8,458
10,440
10,478
10,402
11,379
11,564
12,203
12,915
17,579
15,745
14,600
14,729
13,238
11,214
12,518
15,171
15,528
16,949
17,873
19,025
17,743
21,291
22,842
22,127
22,824
29,005
27,049
23,166
27,382
26,663
25,538
30,649
38,475
50,192
51,030
54,127
49,669
56,847
57,216
55,290
63,760
75,928
87,878
94,337
94,561
98,603
93,558
96,865
107,671
111,140
135,563
175,419
198,565
193,062
204,592
211,315
270,608
353,880
368,147
400,973
440,365
509,427
508,549
500,440
544,996
278,350
331,527
352,928
476,717
546,022
862,709
1,016,053
1,289,188
1,289,1881,016,053862,709546,022476,717352,928331,527278,350544,996500,440508,549509,427440,365400,973368,147353,880270,608211,315204,592193,062198,565175,419135,563111,140107,67196,86593,55898,60394,56194,33787,87875,92863,76055,29057,21656,84749,66954,12751,03050,19238,47530,64925,53826,66327,38223,16627,04929,00522,82422,12722,84221,29117,74319,02517,87316,94915,52815,17112,51811,21413,23814,72914,60015,74517,57912,91512,20311,56411,37910,40210,47810,4408,4586,7857,7927,7096,7747,1376,1416,5904,9255,0405,0345,1435,2215,0084,9162,6012,1231,9991,8412,6562,3812,3402,454
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90,022
70,784
70,726
84,244
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000084,24470,72670,78490,022000000000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
90,022
70,784
70,726
84,244
112,334
119,838
116,562
143,938
152,597
164,768
159,648
175,750
18,848
13,513
10,257
21,054
48,894
169,200
211,998
277,744
277,744211,998169,20048,89421,05410,25713,51318,848175,750159,648164,768152,597143,938116,562119,838112,33484,24470,72670,78490,022000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
1,053
1,164
1,004
762
757
941
916
1,299
2,291
2,575
2,708
2,486
2,411
2,899
2,563
3,240
2,831
3,561
3,304
3,350
2,907
2,879
2,773
4,201
3,108
3,235
5,729
5,289
4,836
6,893
9,578
7,351
7,297
6,995
6,645
5,628
6,963
8,319
9,383
11,245
9,548
9,039
9,512
11,748
10,781
10,457
10,246
12,120
11,071
11,090
12,333
12,005
11,044
14,286
18,869
26,166
23,668
25,807
23,410
24,664
22,178
23,846
26,815
27,202
33,455
38,146
36,745
35,642
29,876
28,827
31,271
36,182
34,366
60,274
46,583
27,253
31,216
30,360
80,782
75,476
63,500
90,906
89,958
108,297
115,014
93,900
89,759
88,135
114,081
112,000
183,672
138,791
313,456
316,114
416,070
416,070316,114313,456138,791183,672112,000114,08188,13589,75993,900115,014108,29789,95890,90663,50075,47680,78230,36031,21627,25346,58360,27434,36636,18231,27128,82729,87635,64236,74538,14633,45527,20226,81523,84622,17824,66423,41025,80723,66826,16618,86914,28611,04412,00512,33311,09011,07112,12010,24610,45710,78111,7489,5129,0399,54811,2459,3838,3196,9635,6286,6456,9957,2977,3519,5786,8934,8365,2895,7293,2353,1084,2012,7732,8792,9073,3503,3043,5612,8313,2402,5632,8992,4112,4862,7082,5752,2911,2999169417577621,0041,1641,053
       Other Current Liabilities 
1,336
1,077
1,312
1,730
1,078
974
1,104
1,264
2,575
2,345
2,500
2,619
2,623
2,134
2,363
3,350
3,310
3,576
3,038
3,507
4,828
3,834
4,388
6,239
7,370
7,168
5,650
5,926
6,219
5,612
5,217
4,987
7,042
7,464
6,320
5,240
5,504
5,350
5,187
4,974
8,275
9,131
7,878
9,182
11,892
10,986
12,025
15,940
15,110
10,944
12,952
10,557
10,090
9,595
11,594
13,967
17,425
19,551
18,569
22,631
24,436
19,193
21,319
25,844
32,571
33,273
33,407
33,950
40,417
39,951
38,424
38,804
51,759
51,213
70,566
54,720
56,878
34,900
70,506
116,682
125,790
122,052
127,804
154,605
147,720
148,914
162,213
71,282
79,345
84,864
104,351
72,617
93,685
189,253
47,547
47,547189,25393,68572,617104,35184,86479,34571,282162,213148,914147,720154,605127,804122,052125,790116,68270,50634,90056,87854,72070,56651,21351,75938,80438,42439,95140,41733,95033,40733,27332,57125,84421,31919,19324,43622,63118,56919,55117,42513,96711,5949,59510,09010,55712,95210,94415,11015,94012,02510,98611,8929,1827,8789,1318,2754,9745,1875,3505,5045,2406,3207,4647,0424,9875,2175,6126,2195,9265,6507,1687,3706,2394,3883,8344,8283,5073,0383,5763,3103,3502,3632,1342,6232,6192,5002,3452,5751,2641,1049741,0781,7301,3121,0771,336
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,249
45,883
0
27,542
24,814
23,732
19,580
18,519
32,943
32,728
36,483
269,753
261,981
299,276
365,748
401,457
335,197
394,224
455,651
455,651394,224335,197401,457365,748299,276261,981269,75336,48332,72832,94318,51919,58023,73224,81427,542045,88339,2490000000000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,926
305
0
442
339
1,588
318
1,929
1,922
2,508
2,562
2,646
3,235
3,279
0
4,640
6,284
6,708
12,989
12,9896,7086,2844,64003,2793,2352,6462,5622,5081,9221,9293181,58833944203051,9260000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
11,383
11,407
11,592
11,899
12,329
12,598
12,777
12,589
17,122
22,708
23,624
24,166
24,880
26,876
28,149
28,265
29,429
29,537
30,065
30,408
32,816
32,558
33,426
34,135
36,555
35,727
35,469
35,968
37,514
36,333
36,294
37,120
46,680
46,816
45,286
45,053
44,223
45,757
46,664
46,035
47,272
49,658
48,686
48,986
50,859
52,745
54,845
54,491
55,055
59,834
60,923
63,857
62,490
60,606
58,057
54,819
66,635
61,057
67,475
64,022
63,727
60,551
57,396
64,632
65,834
68,765
67,549
75,752
78,817
81,004
80,076
77,109
76,680
79,895
97,413
127,725
140,930
130,952
107,695
104,816
118,992
136,200
125,959
130,144
141,157
173,949
156,600
177,020
232,383
287,015
333,575
362,803
412,723
435,327
884,785
884,785435,327412,723362,803333,575287,015232,383177,020156,600173,949141,157130,144125,959136,200118,992104,816107,695130,952140,930127,72597,41379,89576,68077,10980,07681,00478,81775,75267,54968,76565,83464,63257,39660,55163,72764,02267,47561,05766,63554,81958,05760,60662,49063,85760,92359,83455,05554,49154,84552,74550,85948,98648,68649,65847,27246,03546,66445,75744,22345,05345,28646,81646,68037,12036,29436,33337,51435,96835,46935,72736,55534,13533,42632,55832,81630,40830,06529,53729,42928,26528,14926,87624,88024,16623,62422,70817,12212,58912,77712,59812,32911,89911,59211,40711,383
   Common Stock
8,909
8,909
8,909
8,909
8,909
10,109
10,109
10,109
10,109
22,708
23,624
24,166
24,880
26,876
28,149
28,265
29,429
29,537
30,065
30,408
32,816
32,558
33,426
34,135
36,555
35,727
35,469
35,968
37,514
36,333
36,294
26,655
29,655
29,655
29,655
29,655
29,655
29,655
29,655
29,655
29,655
29,655
29,655
29,655
29,655
42,590
42,590
42,372
42,372
42,372
42,372
42,372
42,372
42,372
42,372
42,372
42,372
42,423
42,590
42,590
42,590
42,590
42,590
42,590
42,590
42,590
42,590
42,590
42,590
42,590
42,590
42,590
42,590
42,590
42,590
42,589
42,589
42,589
42,589
42,589
42,589
42,589
42,589
42,589
42,589
42,589
42,589
42,589
42,589
42,589
42,589
42,589
42,589
42,589
0
042,58942,58942,58942,58942,58942,58942,58942,58942,58942,58942,58942,58942,58942,58942,58942,58942,58942,58942,58942,59042,59042,59042,59042,59042,59042,59042,59042,59042,59042,59042,59042,59042,59042,59042,59042,59042,42342,37242,37242,37242,37242,37242,37242,37242,37242,37242,37242,59042,59029,65529,65529,65529,65529,65529,65529,65529,65529,65529,65529,65529,65529,65526,65536,29436,33337,51435,96835,46935,72736,55534,13533,42632,55832,81630,40830,06529,53729,42928,26528,14926,87624,88024,16623,62422,70810,10910,10910,10910,1098,9098,9098,9098,9098,909
   Retained Earnings 
2,474
2,498
2,682
2,990
3,420
2,489
2,668
2,479
7,013
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,465
10,725
10,861
9,312
9,097
8,267
9,801
10,709
10,079
11,316
13,703
12,730
13,030
14,903
10,155
12,256
12,120
12,683
17,245
22,192
26,251
21,053
19,169
16,539
13,300
24,916
19,158
25,010
21,646
21,194
17,925
14,913
20,919
22,099
23,967
23,555
31,081
33,085
35,146
34,217
31,009
28,958
32,281
52,928
-261,820
-332,190
-28,414
-71,201
-89,204
-96,212
-89,129
-116,798
-138,449
-162,962
-163,342
-212,818
-228,548
-238,192
-275,470
-356,802
-453,294
-582,269
-797,038
-775,570
-775,570-797,038-582,269-453,294-356,802-275,470-238,192-228,548-212,818-163,342-162,962-138,449-116,798-89,129-96,212-89,204-71,201-28,414-332,190-261,82052,92832,28128,95831,00934,21735,14633,08531,08123,55523,96722,09920,91914,91317,92521,19421,64625,01019,15824,91613,30016,53919,16921,05326,25122,19217,24512,68312,12012,25610,15514,90313,03012,73013,70311,31610,07910,7099,8018,2679,0979,31210,86110,72510,46500000000000000000000007,0132,4792,6682,4893,4202,9902,6822,4982,474
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000-191-250-250-250-250-250-250000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
346,483
398,977
116,777
136,306
151,430
172,614
182,740
200,167
226,003
261,530
294,702
326,828
362,979
427,985
519,895
647,788
773,507
952,403
1,189,776
0
01,189,776952,403773,507647,788519,895427,985362,979326,828294,702261,530226,003200,167182,740172,614151,430136,306116,777398,977346,483000000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in ARS. All numbers in thousands.